Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study

NCT01927887 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01927887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01927887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Operative Nodal Staging of Thyroid Cancer Using Ultra-Small Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI): Preliminary Study
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2012
Completion date
April 30, 2016
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular thyroid cancer lymph node metastasis, metastatic medullary thyroid cancer, papillary carcinoma of thyroid gland